Premium
Argatroban for anticoagulation during cardiopulmonary bypass in an infant
Author(s) -
DYKE PETER C.,
RUSSO PIERANTONIO,
MUREEBE LEILA,
RUSSO JOANNE,
TOBIAS JOSEPH D.
Publication year - 2005
Publication title -
pediatric anesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.704
H-Index - 82
eISSN - 1460-9592
pISSN - 1155-5645
DOI - 10.1111/j.1460-9592.2005.01417.x
Subject(s) - medicine , argatroban , cardiopulmonary bypass , intensive care medicine , anesthesia , cardiology , platelet , thrombin
Summary Heparin induced thrombocytopenia (HIT) is a rare, but potentially life‐threatening complication of heparin therapy. In patients with HIT, alternative means of anticoagulation are necessary. The authors present an infant with HIT who required anticoagulation during cardiopulmonary bypass for tricuspid valve excision in the treatment of bacterial endocarditis. The direct thrombin inhibitor, argatroban, was successfully used. Previous reports regarding the use of argatroban and other nonheparin anticoagulants for anticoagulation are reviewed and suggestions regarding argatroban dosing in infants are presented.